Taking advantage of this selectivity, the two SIRPα-Fc fusion proteins achieved a biased CD47 binding selectivity, thereby facilitating phagocytosis of tumor cells while avoiding hemagglutination in patients (62, 70). Here, SIRPA is linked to neoplasm.